Browsing: Brain

A novel Alzheimer’s disease treatment drug, lecanemab, developed by Japanese pharmaceutical company Eisai and US firm Biogen, is nearing full approval in the US. Excitement is also building in Japan where the population of Alzheimer’s patients is growing and Prime Minister Fumio Kishida has prioritised dementia. The drug is undergoing an expedited review by the Japanese Pharmaceuticals and Medical Devices Agency and could potentially be approved this autumn.

Ritalin and Cognitive Enhancers: A Double-Edged Sword for Non-ADHD Individuals? Recent research indicates that cognitive enhancers such as Ritalin, commonly…

Near-death experiences (NDEs) are phenomena often characterised by vivid visions, spiritual encounters, and a sense of tranquillity. They have long…

Discover the three best supplements for brain health, mental clarity and acuity to prepare for your upcoming exams